People · Operator
Named in public records as an officer, director or promoter · active 2014–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pnp Therapeutics Inc | — | Biotechnology | Pre-Seed | $1.7M | $6.8M | 2014 |
John K Lankford at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John K Lankford on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Lawrence W> Greer | 1 | 4 |
| David A. Dodd | 1 | 2 |
| William B. Deal | 1 | 1 |
| Frank R. Hunt | 1 | 1 |
| Charles K. Porter | 1 | 1 |
| Claude F. Bennett | 1 | 1 |
| James F. Fuqua | 1 | 1 |
| William B. Parker | 1 | 1 |
| Claude K Bennett | 1 | 1 |
| Eric W Sorscher | 1 | 1 |
| John C. Lankford | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.